quadazocine has been researched along with dynorphins in 10 studies
| Studies (quadazocine) | Trials (quadazocine) | Recent Studies (post-2010) (quadazocine) | Studies (dynorphins) | Trials (dynorphins) | Recent Studies (post-2010) (dynorphins) |
|---|---|---|---|---|---|
| 81 | 0 | 0 | 3,096 | 24 | 514 |
| 81 | 0 | 0 | 368 | 4 | 15 |
| Protein | Taxonomy | quadazocine (IC50) | dynorphins (IC50) |
|---|---|---|---|
| Delta-type opioid receptor | Mus musculus (house mouse) | 0.0077 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.0001 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gannon, RL; Terrian, DM | 1 |
| Agura, V; DeWitt, DS; Faden, AI; Hayes, RL; McIntosh, TK | 1 |
| Faden, AI; Fernyak, S; McIntosh, TK | 1 |
| Adler, MW; Geller, EB; Tiseo, PJ | 1 |
| Huidobro-Toro, JP; Way, EL; Yoshimura, K | 1 |
| Billington, CJ; Gosnell, BA; Levine, AS; Morley, JE | 1 |
| Butelman, ER; Ko, MC; Woods, JH | 1 |
| Butelman, ER; Harris, TJ; Kreek, MJ; Perez, A | 1 |
| Butelman, ER; Harris, TJ; Kreek, MJ | 1 |
| Adapa, ID; Auh, JS; Berzetei-Gurske, IP; Brandt, SR; Craymer, K; Farrington, L; Haggart, D; Kennedy, JM; O'Brien, A; Polgar, WE; Rodriguez, L; Schwartz, RW; Toll, L; White, A | 1 |
10 other study(ies) available for quadazocine and dynorphins
| Article | Year |
|---|---|
Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes.
Topics: Animals; Azocines; Calcium; Dynorphins; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Ethylketocyclazocine; Glutamates; Glutamic Acid; Guinea Pigs; Hippocampus; Male; Potassium; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Synaptosomes | 1992 |
Endogenous opioids may mediate secondary damage after experimental brain injury.
Topics: Animals; Azocines; Blood Flow Velocity; Blood Pressure; Brain; Brain Injuries; Cats; Cerebrovascular Circulation; Dopamine; Dynorphins; Electroencephalography; Endorphins; Enkephalin, Leucine; Female; Intracranial Pressure; Isomerism; Male; Narcotic Antagonists | 1987 |
Endogenous opioids, opiate receptors and traumatic brain injury.
Topics: Animals; Azocines; beta-Endorphin; Brain Chemistry; Brain Injuries; Cats; Cerebrovascular Circulation; Dynorphins; Female; Male; Narcotic Antagonists; Receptors, Opioid | 1986 |
Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Azocines; Cold Temperature; Drug Interactions; Dynorphins; Enkephalins; Injections, Intraventricular; Male; Naloxone; Pyrrolidines; Rats; Rats, Inbred Strains; Reaction Time; Receptors, Opioid | 1988 |
Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.
Topics: Animals; Azocines; Benzomorphans; Cyclazocine; Dynorphins; Endorphins; Enkephalins; Ethylketocyclazocine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Morphine Derivatives; Muscle, Smooth; Naloxone; Narcotic Antagonists | 1982 |
Which opioid receptor mechanism modulates feeding?
Topics: Animals; Azocines; Diprenorphine; Dynorphins; Endorphins; Feeding Behavior; Humans; Mice; Naloxone; Naltrexone; Rats; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, sigma | 1984 |
Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Azocines; Benzomorphans; Capsaicin; Dynorphins; Female; Hot Temperature; Ligands; Macaca mulatta; Male; Naltrexone; Narcotic Antagonists; Pain Measurement; Peptide Fragments; Receptors, Opioid, kappa | 1999 |
Effects of systemically administered dynorphin A(1-17) in rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Azocines; Behavior, Animal; Conditioning, Operant; Cytokines; Dose-Response Relationship, Drug; Dynorphins; Female; Inflammation; Injections, Intravenous; Macaca mulatta; Male; Narcotic Antagonists; Pain Measurement; Prolactin; Reinforcement Schedule | 1999 |
Effects of E-2078, a stable dynorphin A(1-8) analog, on sedation and serum prolactin levels in rhesus monkeys.
Topics: Animals; Azocines; Dose-Response Relationship, Drug; Dynorphins; Female; Hypnotics and Sedatives; Injections, Subcutaneous; Macaca mulatta; Male; Motor Activity; Muscle Relaxation; Naltrexone; Narcotic Antagonists; Peptide Fragments; Prolactin; Pyrrolidines; Receptors, Opioid, kappa; Time Factors | 1999 |
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
Topics: Animals; Aorta, Thoracic; Cocaine; Cyclic AMP; Electric Stimulation; Guinea Pigs; Humans; Ileum; In Vitro Techniques; Male; Mice; Muscle, Smooth; Opioid-Related Disorders; Rats; Receptors, Dopamine; Receptors, Opioid; Receptors, Serotonin; Substance-Related Disorders | 1998 |